Pages that link to "Q51693206"

The following pages link to Mercedes Garayoa (Q51693206):

Displaying 42 items.

• Dasatinib as a bone-modifying agent: anabolic and anti-resorptive effects (Q28730433) (← links)
• Adrenomedullin is a cross-talk molecule that regulates tumor and mast cell function during human carcinogenesis (Q30445142) (← links)
• Multiple myeloma mesenchymal stromal cells: Contribution to myeloma bone disease and therapeutics (Q34038854) (← links)
• Adrenomedullin in mammalian embryogenesis. (Q34580825) (← links)
• Phenotypic, genomic and functional characterization reveals no differences between CD138++ and CD138low subpopulations in multiple myeloma cell lines (Q35128148) (← links)
• The epoxyketone-based proteasome inhibitors carfilzomib and orally bioavailable oprozomib have anti-resorptive and bone-anabolic activity in addition to anti-myeloma effects. (Q37166798) (← links)
• Myoendocrine-like cells in invertebrates: occurrence of noncardiac striated secretory-like myocytes in the gut of the ant Formica polyctena. (Q38571231) (← links)
• Synergistic DNA-damaging effect in multiple myeloma with the combination of zalypsis, bortezomib and dexamethasone. (Q38751108) (← links)
• The Novel Pan-PIM Kinase Inhibitor, PIM447, Displays Dual Antimyeloma and Bone-Protective Effects, and Potently Synergizes with Current Standards of Care (Q38839531) (← links)
• In vivo murine model of acquired resistance in myeloma reveals differential mechanisms for lenalidomide and pomalidomide in combination with dexamethasone. (Q38968027) (← links)
• Preclinical activity of the oral proteasome inhibitor MLN9708 in Myeloma bone disease. (Q39028178) (← links)
• CD20 positive cells are undetectable in the majority of multiple myeloma cell lines and are not associated with a cancer stem cell phenotype (Q39399792) (← links)
• Zalypsis has in vitro activity in acute myeloid blasts and leukemic progenitor cells through the induction of a DNA damage response. (Q39590174) (← links)
• Aplidin, a marine organism-derived compound with potent antimyeloma activity in vitro and in vivo (Q39966416) (← links)
• Accumulation of hypoxia-inducible factor-1alpha is limited by transcription-dependent depletion. (Q40421501) (← links)
• Adrenomedullin expression in a rat model of acute lung injury induced by hypoxia and LPS. (Q40484814) (← links)
• Expression of complement factor H by lung cancer cells: effects on the activation of the alternative pathway of complement. (Q40519834) (← links)
• Mitogen-activated protein kinase phosphatase-1 is overexpressed in non-small cell lung cancer and is an independent predictor of outcome in patients. (Q40550067) (← links)
• Effects of acute hypoxia and lipopolysaccharide on nitric oxide synthase-2 expression in acute lung injury. (Q40644183) (← links)
• Preclinical anti-myeloma activity of EDO-S101, a new bendamustine-derived molecule with added HDACi activity, through potent DNA damage induction and impairment of DNA repair (Q41088379) (← links)
• Transcriptomic profile induced in bone marrow mesenchymal stromal cells after interaction with multiple myeloma cells: implications in myeloma progression and myeloma bone disease (Q42158465) (← links)
• RAF265, a dual BRAF and VEGFR2 inhibitor, prevents osteoclast formation and resorption. Therapeutic implications. (Q43845117) (← links)
• Transcriptomic rationale for the synergy observed with dasatinib + bortezomib + dexamethasone in multiple myeloma (Q44004521) (← links)
• The insulin-like growth factor-I receptor inhibitor NVP-AEW541 provokes cell cycle arrest and apoptosis in multiple myeloma cells. (Q44541080) (← links)
• The kinesin spindle protein inhibitor filanesib enhances the activity of pomalidomide and dexamethasone in multiple myeloma. (Q47873839) (← links)
• Depressed adrenomedullin in the embryonic transforming growth factor-beta1 null mouse becomes elevated postnatally. (Q47989091) (← links)
• Downregulation of hnRNP A2/B1 expression in tumor cells under prolonged hypoxia (Q51693184) (← links)
• Effects of IL-8 Up-Regulation on Cell Survival and Osteoclastogenesis in Multiple Myeloma (Q51703229) (← links)
• Zalypsis: a novel marine-derived compound with potent antimyeloma activity that reveals high sensitivity of malignant plasma cells to DNA double-strand breaks. (Q54787043) (← links)
• Sphingosine-1-phosphate activates chemokine-promoted myeloma cell adhesion and migration involving α4β1 integrin function (Q58498450) (← links)
• Detailed characterization of multiple myeloma circulating tumor cells shows unique phenotypic, cytogenetic, functional, and circadian distribution profile (Q60203403) (← links)
• Mesenchymal stem cells from multiple myeloma patients display distinct genomic profile as compared with those from normal donors (Q60203690) (← links)
• Alternative splicing of the proadrenomedullin gene results in differential expression of gene products (Q61867166) (← links)
• Androgen-independent expression of adrenomedullin and peptidylglycine α-amidating monooxygenase in human prostatic carcinoma (Q63966373) (← links)
• Light and electron microscopic study of the hindgut of the ant (Formica nigricans, hymenoptera): I. Structure of the ileum (Q73224328) (← links)
• Malpighian tubules of Formica polyctena (Hymenoptera): Light and electron microscopic study (Q88980499) (← links)
• Dihydropyrimidine-2-thiones as Eg5 inhibitors and L-type calcium channel blockers: potential antitumour dual agents (Q91046603) (← links)
• Biological Background of Resistance to Current Standards of Care in Multiple Myeloma (Q91443460) (← links)
• Preclinical evaluation of the simultaneous inhibition of MCL-1 and BCL-2 with the combination of S63845 and venetoclax in multiple myeloma (Q92002045) (← links)
• Protein Translation Inhibition is Involved in the Activity of the Pan-PIM Kinase Inhibitor PIM447 in Combination with Pomalidomide-Dexamethasone in Multiple Myeloma (Q100312939) (← links)
• Targeting aberrant DNA methylation in mesenchymal stromal cells as a treatment for myeloma bone disease (Q112593611) (← links)
• Bone Marrow Mesenchymal Stromal Cells in Multiple Myeloma: Their Role as Active Contributors to Myeloma Progression (Q112767251) (← links)